Network origin in Daniel Zurr first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985.
11
| Extinct | Chemicals: Specialty | 11 |
| Public Company | Pharmaceuticals: Generic | 5 | |
| Public Company | Chemicals: Agricultural | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Daniel Zurr via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| VERU INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MONSANTO | Wholesale Distributors | Chief Executive Officer Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal | |
| Medica III Management Co. | Director/Board Member | ||
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Masters Business Admin | |
DenX Medical Software Systems Ltd.
 DenX Medical Software Systems Ltd. Medical SpecialtiesHealth Technology DenX Ltd. is engaged in manufacturing of dental equipment. The firm develops and markets image guided technology for dental training and clinical implementation. The company was founded by Hayka Alon in 1994 and is headquartered in Jerusalem, Israel. | Medical Specialties | Chairman | |
Yissum Research Development Co. Ltd.
 Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | Investment Managers | Director/Board Member Chairman | |
| Drexel University | College/University | Undergraduate Degree Doctorate Degree | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Director/Board Member | |
| SOL-GEL TECHNOLOGIES LTD. | Pharmaceuticals: Major | Director/Board Member | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree Graduate Degree Masters Business Admin Graduate Degree | |
| University of Kansas | College/University | Doctorate Degree Doctorate Degree | |
| UNIVO PHARMACEUTICALS LTD | Biotechnology | Chairman | |
| Technion-Israel Institute of Technology | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
TransPharma Medical Ltd.
 TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | Pharmaceuticals: Major | Director/Board Member | |
| INTERCURE LTD. | Medical Specialties | Chairman Director/Board Member | |
| Weizmann Institute of Science | College/University | Doctorate Degree | |
| BIOLINERX LTD. | Pharmaceuticals: Major | Chairman | |
| PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MEDIWOUND LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Biotechnology | Chairman | |
Interpharm Laboratories Ltd.
 Interpharm Laboratories Ltd. BiotechnologyHealth Technology Part of Merck KGaA, Interpharm Laboratories Ltd. is an Israeli company that develops recombinant cytokines for the treatment of viral infections, cancer and autoimmune diseases. The company is based in Rehovot, Israel. The company was founded by Israel Makov. | Biotechnology | Chief Executive Officer | |
Regentis Biomaterials Ltd.
 Regentis Biomaterials Ltd. BiotechnologyHealth Technology Regentis Biomaterials Ltd. engages in the research and development of proprietary hydrogels for local repair of damaged cartilage and bone. Its product is GelrinC. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel. | Biotechnology | Chairman | |
Gardia Medical Ltd.
 Gardia Medical Ltd. Medical SpecialtiesHealth Technology Gardia Medical specializes in the development of catheter-based delivery systems that easily integrate with the standard workflow of stenting and other cardiovascular intervention procedures. It offers wire-independent distal filtration Embolic Protection Device (EPD), compatible with standard guide wires. The company was founded by Benjamin Spenser and Uri Rosenshein in 2006 and is headquartered in Hadera, Israel. | Medical Specialties | Chairman | |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Biotechnology | Chairman | |
The Tel Aviv Stock Exchange (Investment Management)
 The Tel Aviv Stock Exchange (Investment Management) Investment Banks/BrokersFinance Part of The Tel Aviv Stock Exchange Ltd., The Tel Aviv Stock Exchange (Investment Management) is a company that provides fund management services. The company is based in Tel Aviv, Israel. Ittai Ben Zeev has been the CEO of the Israeli company since 2017. | Investment Banks/Brokers | Director/Board Member | |
| ALLMED SOLUTIONS LTD | Pharmaceuticals: Other | Director/Board Member | |
| PAINREFORM LTD. | Pharmaceuticals: Major | Chairman | |
BioMAS Ltd.
 BioMAS Ltd. Pharmaceuticals: MajorHealth Technology BioMAS Ltd. is an Israeli pharmaceutical company that was founded in 2000. The private company is based in Jerusalem, Israel and develops drugs that are based on tellurium. | Pharmaceuticals: Major | Chairman | |
| Amorphical Ltd. | Chairman | ||
| Protalix Ltd. | Director/Board Member | ||
| Wyeth Laboratories, Inc. | Corporate Officer/Principal | ||
Integra Holdings Ltd.
 Integra Holdings Ltd. MiscellaneousMiscellaneous Integra Holdings Ltd. operates as a holding company. It invests in the pharmaceutical industry. The company was founded in 2012 and is headquartered in Jerusalem, Israel. | Miscellaneous | Director/Board Member | |
| Medingalil Ltd. | Director/Board Member | ||
Anthill Ventures
 Anthill Ventures Investment ManagersFinance Anthill Scale Ventures is a venture capital firm. The firm was founded in 2016 by Prasad Vanga. The firm headquartered in Hyderabad, India with additional office in Singapore, US and Israel. | Investment Managers | Private Equity Investor | |
Barcode Diagnostics Ltd.
 Barcode Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology Barcode Diagnostics Ltd. is engaged in developing a product that assesses the efficacy of different cancer drugs directly on the tumor within the body to select the optimal personalized treatment for each patient. The company was founded by Ronen Eavri, Annie Sabbah, and Avi Schroeder in February 2017 and is headquartered in Nazareth, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Zori Medica 3 Ltd. | Director/Board Member | ||
| Zori Medica (2010) Ltd. | Director/Board Member | ||
| Tzory Medica (Management) Israel Ltd. | Director/Board Member | ||
| A.G. Arhimedes Ltd. | Director/Board Member | ||
D Pharm Ltd.
 D Pharm Ltd. BiotechnologyHealth Technology D Pharm Ltd. provides drug development services. | Biotechnology | Chairman | |
| SCOPUS BIOPHARMA INC. | Pharmaceuticals: Other | Director/Board Member | |
| Zori Medica (Management) Israel Ltd. | Director/Board Member | ||
| A.D. Geller Enterprises Ltd. | Director/Board Member |
Statistics
International
| Israel | 38 |
| United States | 13 |
| India | 2 |
Sectoral
| Health Technology | 26 |
| Consumer Services | 8 |
| Finance | 5 |
| Distribution Services | 2 |
| Technology Services | 2 |
Operational
| Director/Board Member | 98 |
| Chairman | 50 |
| Corporate Officer/Principal | 40 |
| Independent Dir/Board Member | 19 |
| Undergraduate Degree | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Robert Shapiro | 31 |
| Aharon Schwartz | 29 |
| Bruce Carter | 25 |
| Ehud Geller | 24 |
| David R. Bethune | 18 |
| John M. Reher | 16 |
| Meron Mann | 15 |
| Daniel Flynn | 11 |
| Ellen R. Hoffing | 10 |
| Eliyahu Hurvitz | 9 |
| Ben-Zion Weiner | 8 |
| Mary Ann Leeper | 7 |
| Arthur Lee Campbell | 7 |
| William R. Mattson | 7 |
| Daniel C. Plotkin | 6 |
- Stock Market
- Insiders
- Daniel Zurr
- Company connections
